• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌的肿瘤微环境与免疫治疗。

Tumor microenvironment and immunotherapy of oral cancer.

机构信息

Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, People's Republic of China.

出版信息

Eur J Med Res. 2022 Oct 8;27(1):198. doi: 10.1186/s40001-022-00835-4.

DOI:10.1186/s40001-022-00835-4
PMID:36209263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9547678/
Abstract

Oral cancer is one of the most common malignant tumors of the head and neck, not only affects the appearance, but also affects eating and even endangers life. The clinical treatments of oral cancer mainly include surgery, radiotherapy, and chemotherapy. However, unsatisfactory therapeutic effect and toxic side effects are still the main problems in clinical treatment. Tumor microenvironment (TME) is not only closely related to the occurrence, growth, and metastasis of tumor but also works in the diagnosis, prevention, and treatment of tumor and prognosis. Future studies should continue to investigate the relationship of TME and oral cancer therapy. This purpose of this review was to analyze the characteristics of oral cancer microenvironment, summarize the traditional oral cancer therapy and immunotherapy strategies, and finally prospect the development prospects of oral cancer immunotherapy. Immunotherapy targeting tumor microenvironment is expected to provide a new strategy for clinical treatment of oral cancer.

摘要

口腔癌是头颈部最常见的恶性肿瘤之一,不仅影响外观,还影响进食,甚至危及生命。口腔癌的临床治疗主要包括手术、放疗和化疗。然而,不尽如人意的治疗效果和毒副作用仍然是临床治疗中的主要问题。肿瘤微环境(TME)不仅与肿瘤的发生、生长和转移密切相关,而且在肿瘤的诊断、预防和治疗以及预后中也起着重要作用。未来的研究应继续探讨 TME 与口腔癌治疗的关系。本综述旨在分析口腔癌微环境的特征,总结传统的口腔癌治疗和免疫治疗策略,最后展望口腔癌免疫治疗的发展前景。靶向肿瘤微环境的免疫治疗有望为口腔癌的临床治疗提供新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/cb660a7cb906/40001_2022_835_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/2a32a65b4bd2/40001_2022_835_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/8400b5cc1a3f/40001_2022_835_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/cb660a7cb906/40001_2022_835_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/2a32a65b4bd2/40001_2022_835_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/8400b5cc1a3f/40001_2022_835_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3e/9548213/cb660a7cb906/40001_2022_835_Fig3_HTML.jpg

相似文献

1
Tumor microenvironment and immunotherapy of oral cancer.口腔癌的肿瘤微环境与免疫治疗。
Eur J Med Res. 2022 Oct 8;27(1):198. doi: 10.1186/s40001-022-00835-4.
2
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.工程纳米粒子靶向重塑肿瘤微环境以改善癌症免疫治疗。
Theranostics. 2019 Jan 1;9(1):126-151. doi: 10.7150/thno.29431. eCollection 2019.
3
Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.肿瘤微环境中的新兴免疫检查点:对癌症免疫治疗的影响。
Cancer Lett. 2021 Jul 28;511:68-76. doi: 10.1016/j.canlet.2021.04.021. Epub 2021 May 3.
4
A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.空间转录组揭示了免疫治疗获得性耐药的口腔癌中肿瘤和肿瘤微环境的变化。
Biomolecules. 2023 Nov 22;13(12):1685. doi: 10.3390/biom13121685.
5
Biological implications of the immune factors in the tumour microenvironment of oral cancer.口腔癌肿瘤微环境中免疫因素的生物学意义。
Arch Oral Biol. 2022 Jan;133:105294. doi: 10.1016/j.archoralbio.2021.105294. Epub 2021 Oct 24.
6
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.肿瘤微环境中 CD39-CD73-eAdo/A2aR 研究的现状和趋势:文献计量学分析。
Front Immunol. 2024 Aug 12;15:1427380. doi: 10.3389/fimmu.2024.1427380. eCollection 2024.
7
Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.头颈部癌症中微环境驱动的肿瘤内异质性:精准医学的临床挑战和机遇。
Drug Resist Updat. 2022 Jan;60:100806. doi: 10.1016/j.drup.2022.100806. Epub 2022 Jan 25.
8
The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.肿瘤微环境与结直肠癌治疗策略的作用。
Front Immunol. 2021 Dec 2;12:792691. doi: 10.3389/fimmu.2021.792691. eCollection 2021.
9
Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.提高乳腺癌对免疫疗法的反应——寻找肿瘤微环境的阿喀琉斯之踵。
Curr Oncol Rep. 2021 Mar 23;23(5):55. doi: 10.1007/s11912-021-01040-y.
10
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment.胰腺癌中的免疫抑制、免疫逃逸和免疫治疗:聚焦于肿瘤微环境
Cell Oncol (Dordr). 2023 Feb;46(1):17-48. doi: 10.1007/s13402-022-00741-1. Epub 2022 Nov 11.

引用本文的文献

1
A 40-year bibliometric analysis of global research on neoadjuvant chemotherapy for oral cancer (1985-2024).口腔癌新辅助化疗全球研究的40年文献计量分析(1985 - 2024年)
Discov Oncol. 2025 Aug 27;16(1):1642. doi: 10.1007/s12672-025-03411-4.
2
Ultrasound-Responsive Drug Delivery System Based on Piezoelectric Catalytic Mechanisms.基于压电催化机制的超声响应药物递送系统
J Funct Biomater. 2025 Aug 21;16(8):304. doi: 10.3390/jfb16080304.
3
Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma.

本文引用的文献

1
EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms.EXTL3 可作为前列腺癌预后和免疫治疗的潜在标志物及其潜在机制。
Eur J Med Res. 2022 Jul 11;27(1):115. doi: 10.1186/s40001-022-00740-w.
2
Natural killer cells and acute myeloid leukemia: promises and challenges.自然杀伤细胞与急性髓系白血病:前景与挑战。
Cancer Immunol Immunother. 2022 Dec;71(12):2849-2867. doi: 10.1007/s00262-022-03217-1. Epub 2022 May 31.
3
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
细菌脂多糖与口腔鳞状细胞癌潜在关系的生物信息学分析及实验验证
PLoS One. 2025 Aug 21;20(8):e0329231. doi: 10.1371/journal.pone.0329231. eCollection 2025.
4
Study on the Effect of Antibiotics on the Efficacy of PD-1 Inhibitors and Its Regulatory Mechanism via the Intestinal Bacterial Community.抗生素对PD-1抑制剂疗效的影响及其通过肠道菌群的调控机制研究
Biochem Genet. 2025 Jul 12. doi: 10.1007/s10528-025-11189-x.
5
Oral squamous cell carcinoma: Insights into cellular heterogeneity, drug resistance, and evolutionary trajectories.口腔鳞状细胞癌:对细胞异质性、耐药性及进化轨迹的见解
Cell Biol Toxicol. 2025 Jun 12;41(1):101. doi: 10.1007/s10565-025-10048-0.
6
Molecular insights into immune evasion in head and neck squamous cell carcinomas: Toward a promising treatment strategy.头颈部鳞状细胞癌免疫逃逸的分子见解:迈向一种有前景的治疗策略。
Oncol Res. 2025 May 29;33(6):1271-1282. doi: 10.32604/or.2025.062207. eCollection 2025.
7
Salivary Extracellular Vesicles in Detection of Head and Neck Cancers: A Systematic Review.唾液细胞外囊泡在头颈部癌症检测中的应用:一项系统综述
Int J Nanomedicine. 2025 May 26;20:6757-6775. doi: 10.2147/IJN.S520288. eCollection 2025.
8
Impact of surgical margins status on survival outcomes in oral cavity squamous cell carcinoma: a systematic review and meta-analysis.手术切缘状态对口腔鳞状细胞癌生存结局的影响:一项系统评价和荟萃分析
Acta Otorhinolaryngol Ital. 2025 May;45(Suppl. 1):S2-S14. doi: 10.14639/0392-100X-suppl.1-45-2025-N1044.
9
pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer.pH响应性纳米疫苗联合抗PD-1抗体用于增强乳腺癌免疫治疗
Theranostics. 2025 Apr 28;15(12):6022-6043. doi: 10.7150/thno.107200. eCollection 2025.
10
Taiwan Green Propolis Nanoparticles Induce Antiproliferation and Apoptosis in Oral Cancer Cells.台湾绿蜂胶纳米粒子诱导口腔癌细胞增殖抑制和凋亡
Biomedicines. 2025 Apr 9;13(4):921. doi: 10.3390/biomedicines13040921.
免疫检查点阻断在具有侵袭性的肺类癌中的应用:我们箭袋中的又一支箭?
J Clin Med. 2022 Feb 16;11(4):1019. doi: 10.3390/jcm11041019.
4
Emerging Role of Autophagy in the Development and Progression of Oral Squamous Cell Carcinoma.自噬在口腔鳞状细胞癌发生发展中的新作用
Cancers (Basel). 2021 Dec 7;13(24):6152. doi: 10.3390/cancers13246152.
5
Contextual reprogramming of CAR-T cells for treatment of HER2 cancers.针对 HER2 癌症的 CAR-T 细胞的上下文重编程。
J Transl Med. 2021 Nov 7;19(1):459. doi: 10.1186/s12967-021-03132-6.
6
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.Trabectedin 通过抑制肿瘤相关巨噬细胞来改善抗 PD-1 治疗的抗肿瘤适应性免疫。
Eur J Immunol. 2021 Nov;51(11):2677-2686. doi: 10.1002/eji.202149379. Epub 2021 Oct 8.
7
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine.用治疗性 HPV 疫苗 DNA 控制 HLA-A2(AAD)转基因小鼠中自发性 HPV16 E6/E7 表达的口腔癌。
J Biomed Sci. 2021 Sep 13;28(1):63. doi: 10.1186/s12929-021-00759-x.
8
Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy.结合甘露糖受体介导的纳米疫苗和基因调控的PD-L1阻断以增强癌症免疫治疗。
Bioact Mater. 2021 Jun 4;7:167-180. doi: 10.1016/j.bioactmat.2021.05.036. eCollection 2022 Jan.
9
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment.肿瘤微环境中的炎症、细胞外基质重塑和蛋白质稳态
Int J Mol Sci. 2021 Jul 28;22(15):8102. doi: 10.3390/ijms22158102.
10
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的肿瘤微环境与免疫逃逸。
Int J Oral Sci. 2021 Aug 2;13(1):24. doi: 10.1038/s41368-021-00131-7.